8-530.6:

Nuclear medicine therapy: Therapy with unsealed radionuclides: Intravenous therapy with radioactive receptor-targeting drugs

8-530.61 Receptor-mediated radionuclide therapy with chelator-conjugated somatostatin analogs produced internally for individual patients
8-530.62 Receptor-mediated radionuclide therapy with chelator-conjugated somatostatin analogs not produced for individual patients
8-530.6x Other

Note

Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.

Source

Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).